Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ahmed, S. N.
Right arrow Articles by Rashid, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ahmed, S. N.
Right arrow Articles by Rashid, Y.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 28:1837-1838, 2005
© 2005 by the American Diabetes Association, Inc.


Letters: Observations

Anticraving Effects of Topiramate in a Diabetic Patient

Syed Nizamuddin Ahmed, MD, FRCPC1 and Yasmin Rashid, MD2

1 Division of Neurology, University of Alberta Hospital, Edmonton, Alberta, Canada
2 All Well Primary Care Centre, Edmonton, Alberta, Canada

Address correspondence to S. Nizam Ahmed, MD, FRCPC, 2E3.12. University of Alberta Hospital, Edmonton, AB T6G 2B7, Canada. E-mail: snahmed@ualberta.ca

The first 20% of the full text of this article appears below.

Topiramate is an effective antiepileptic medication. It holds promise in the care of diabetic patients by virtue of its effect on weight loss (1). It is also reported efficacious as an adjunct in the treatment of alcohol dependence (2) and in the management of binge-eating disorder (3). We report a case illustrating the potential anticraving effects of topiramate against chocolate, leading to significantly improved glycemic control in an epileptic patient with concurrent diabetes.

A 67-year-old woman presented to the epilepsy clinic in September 2003 for evaluation of "possible seizures" and was subsequently treated with topiramate. She also had an 11-year . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2005 by the American Diabetes Association.